AAV5 vector delivered ANGPTL3 gene therapy (uniQure BV)

N/A

Report date: 2025/01/26 18:05:18

NME

Base Information

Drug NameAAV5 vector delivered ANGPTL3 gene therapy (uniQure BV)

Drug Alias NameAAV gene therapy (uniQure BV)AAV5-ANGPTL3 gene therapy (uniQure BV)ANGPTL3 artificial-miRNA therapy (uniQure BV)adeno-associated virus gene therapy (uniQure BV)AAV5-ANGPTL3

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionAngiopoietin like 3 modulators

TargetsAngiopoietin like 3

Therapy Area/IndicationsLipid Metabolism Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniqure Nv

China Registration ClassN/A

Develop Information

Active CompaniesUniqure Nv

Inactive CompaniesN/A

Active IndicationsLipid Metabolism Disorders

Inactive IndicationsN/A

Other Information

ATC CodeN/A